trending Market Intelligence /marketintelligence/en/news-insights/trending/mv0rjj5om3jx-gptg73eva2 content esgSubNav
In This List

Spero names replacement for outgoing director

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Spero names replacement for outgoing director

Spero Therapeutics Inc., a clinical-stage biopharmaceutical company based in Cambridge, Mass., named John Pottage Jr. to its board.

Pottage is filling the position of outgoing director Casper Breum on the board of the company, which develops and commercializes treatments for multidrug-resistant bacterial infections.

Pottage is currently serving as senior vice president and chief scientific and medical officer of ViiV Healthcare UK Ltd.